⌘K
Loading ticker…
As of 2026-08-24, Oric Pharmaceuticals, Inc. Common Stock (ORIC) has a 3-month relative strength percentile of 96 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 62. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.0%, relative volume 0.72×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
ORIC is in a stage 2 uptrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 18.4% / 26.7%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
ORIC is held by 21 ETFs as of May 2026. Top owner: SCHA at 0.01% weight, $3M notional. Top 3 carry $7M.
Held by 49 ETFs · $129M across latest filings · largest weight 0.78% (BBC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $3M | −0.01 pp |
| VTWO | 0.02% | $3M | −0.01 pp |
| AVSC | 0.04% | $1M | −0.03 pp |
| VHTVanguard Health Care ETF | 0.01% | $1M | — |
| CANC | 0.28% | $490K | −0.02 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.03% |
| $469K |
| — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $396K | — |
| ONEQ | 0.00% | $346K | new |
| VTWV | 0.02% | $318K | −0.02 pp |
| VTWG | 0.01% | $150K | — |
Showing 10 of 21 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ORIC Jan avg: 17.52% median: 22.44% win: 75% σ: 14.83% n: 4 2022-04-12 → 2026-07-31 | ORIC Feb avg: 0.59% median: -2.90% win: 50% σ: 27.19% n: 4 2022-04-12 → 2026-07-31 | ORIC Mar avg: 0.07% median: 1.06% win: 50% σ: 24.83% n: 4 2022-04-12 → 2026-07-31 | ORIC Apr avg: -18.61% median: -22.02% win: 20% σ: 15.21% n: 5 2022-04-12 → 2026-07-31 | ORIC May avg: 5.70% median: 0.60% win: 60% σ: 21.87% n: 5 2022-04-12 → 2026-07-31 | ORIC Jun avg: 23.83% median: 28.17% win: 80% σ: 27.73% n: 5 2022-04-12 → 2026-07-31 | ORIC Jul avg: 9.66% median: 2.22% win: 60% σ: 28.93% n: 5 2022-04-12 → 2026-07-31 | ORIC Aug avg: -0.77% median: -1.43% win: 50% σ: 6.85% n: 4 2022-04-12 → 2026-07-31 (current) | ORIC Sep avg: -5.96% median: -4.34% win: 25% σ: 20.57% n: 4 2022-04-12 → 2026-07-31 | ORIC Oct avg: -1.16% median: 0.59% win: 50% σ: 13.54% n: 4 2022-04-12 → 2026-07-31 | ORIC Nov avg: 12.05% median: 11.73% win: 75% σ: 18.73% n: 4 2022-04-12 → 2026-07-31 | ORIC Dec avg: 7.72% median: -1.01% win: 50% σ: 42.62% n: 4 2022-04-12 → 2026-07-31 |